Our Voices Matter: Intervention for Depression in Youth

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-20
SponsorAnn & Robert H Lurie Children's Hospital of Chicago

About this trial

Over 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceration) that produce hostile environments that contribute to psychological distress, elevated allostatic load, and an elevated risk for chronic diseases and premature death, concentrated within Black and Latinx populations. While the connection between SRD and health is well documented, few studies provide evidence on strategies to reduce SRD and mitigate consequences on psychological and physiological outcomes. Thus, there is a critical need to rigorously test interventions that improve the mental and physical health of Black and Latinx populations, beginning in adolescence. The study's specific aims are to 1) Determine whether a racial justice activism behavioral intervention prevents and reduces depressive symptoms in Black and Latinx adolescents and young adults and 2) Determine whether a racial justice activism behavioral intervention lowers allostatic load scores in Black and Latinx adolescents and young adults. To accomplish these aims, the team will conduct a stage II group-based, multi-component, and multilevel randomized behavioral clinical trial. The investigators will collect psychological and physiological measures at baseline, then at defined intervals for 2 years post the racial justice activism intervention.

Eligibility criteria

Qualifiers

15-20 years old

Identify as Black and/ or Latinx

Speak English

Disqualifiers

Younger than 15 years old, or older than 20 years old

Unable to attend the in-person sessions

Non-fluent English speaker

Do not identify as Black or Latinx

Trial design

Treatments tested in this trial

  • Racial Justice Activism Intervention ARM
  • Adulting 101- Control Arm

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ann & Robert H Lurie Children's Hospital of Chicago

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Policy Research Associates

Collaborator